Kathleen L McGuire Selected Research

Therapeutics

1/2022	Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer.
12/2016	A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen L McGuire Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 11/2004
5	Colonic Neoplasms (Colon Cancer) 10/2010 - 03/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2016
1	Non-Muscle Invasive Bladder Neoplasms 12/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Microsatellite Instability 10/2010
1	Inflammation (Inflammations) 10/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2007
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2006
1	T-Cell Leukemia (Leukemia, T Cell) 07/2005
1	Leukemia 07/2005

Drug/Important Bio-Agent (IBA)

5	sansalvamide AIBA 02/2008 - 03/2006
3	Biological ProductsIBA 10/2010 - 08/2006
2	Pharmaceutical PreparationsIBA 02/2008 - 05/2007
1	IntegrinsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 10/2010
1	ThymidineIBA 09/2007
1	VaccinesIBA 08/2006
1	Interleukin-2 (IL2)IBA 07/2005
1	tax Gene Products (tax Gene Product)IBA 07/2005
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 11/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2016
1	Immunotherapy 01/2022
1	Intravesical Administration 12/2016